Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CRSP
Stock Latest News
Market News
Here’s Why Cathie Wood Walked Away from PLTR and ACHR Stocks
4d ago
ACHR
ARKK
Premium
Weekend Updates
Illinois Tool Works, Wynn Resorts, Agree Realty, Crispr Therapeutics, Super Micro Computer: Trending by Analysts
8d ago
ADC
ITW
Premium
The Fly
Crispr Therapeutics price target lowered to $42 from $56 at Barclays
9d ago
CRSP
Premium
Ratings
Promising Developments and Pipeline Expansion at Crispr Therapeutics AG Support Buy Rating
10d ago
CRSP
Premium
Company Announcements
CRISPR Therapeutics Reports Q1 2025 Progress and Financials
10d ago
CRSP
Premium
The Fly
Cathie Wood’s ARK Investment buys 329K shares of Crispr Therapeutics today
11d ago
CRSP
Premium
The Fly
Crispr Therapeutics price target lowered to $79 from $80 at BofA
11d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Strong Buy Rating Backed by Promising Clinical Data and Strategic Collaborations
11d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Promising Trial Results and Strong Financial Position Support Buy Rating
11d ago
CRSP
Premium
The Fly
Crispr Therapeutics upgraded to Buy from Hold at Clear Street
11d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Balancing Growth Potential with Profitability Challenges – Hold Rating
11d ago
CRSP
Premium
The Fly
Crispr Therapeutics reports Q1 EPS ($1.58), consensus ($1.28)
12d ago
CRSP
Premium
Market News
Cathie Wood Makes Surprising Moves by Buying AMD and Selling CRISPR
18d ago
AMD
ARKK
Premium
Stock Analysis & Ideas
‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital
26d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Promising Growth with Casgevy Launch and Innovative Pipeline
26d ago
CRSP
Premium
The Fly
Crispr Therapeutics price target lowered to $80 from $86 at BofA
1M ago
CRSP
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
KC
WW
Premium
Market News
‘Buy these Stocks that Innovate,’ Says Cathie Wood
1M ago
TEM
CRSP
Premium
Ratings
Crispr Therapeutics AG: Strong Market Position and Financial Stability Justify Buy Rating
1M ago
CRSP
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
DNA
EXK
Premium
The Fly
Crispr Therapeutics granted orphan status for follicular lymphoma treatment
1M ago
CRSP
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
2M ago
CRSP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
